Q1 2025 · 13F-HR
Lion Point Capital, LPholdings as filed
Filed 2025-05-15 · accession 0001013594-25-000673
$15.7M
Reported value
21
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 457669307 | INSM | INSMED INC | $2.3M | 14.8% | 30,500 | Common | SOLE |
| 039697107 | ARDX | ARDELYX INC | $1.6M | 10.5% | 335,400 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $1.3M | 8.00% | 79,000 | Common | SOLE |
| 31447P100 | FENC | FENNEC PHARMACEUTICALS INC | $1.2M | 7.60% | 195,700 | Common | SOLE |
| G52694109 | KNSA | KINIKSA PHARMACEUTICALS LTD | $1.0M | 6.50% | 45,900 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $898,820 | 5.73% | 26,000 | Common | SOLE |
| 08205P209 | BNTC | BENITEC BIOPHARMA INC | $806,620 | 5.15% | 62,000 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $795,000 | 5.07% | 500,000 | Common | SOLE |
| G29687103 | AVDL | AVADEL PHARMACEUTICALS PLC | $772,821 | 4.93% | 98,700 | Common | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $724,132 | 4.62% | 46,300 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $675,675 | 4.31% | 55,000 | Common | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $629,950 | 4.02% | 146,500 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $545,708 | 3.48% | 22,700 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $526,184 | 3.36% | 10,600 | Common | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $439,100 | 2.80% | 548,806 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $412,913 | 2.63% | 57,750 | Common | SOLE |
| 09609G209 | BLE0 | BLUEBIRD BIO INC | $385,091 | 2.46% | 78,912 | Common | SOLE |
| 81750R102 | MCRB1EUR | SERES THERAPEUTICS INC | $238,533 | 1.52% | 340,761 | Common | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $221,665 | 1.41% | 644,000 | Common | SOLE |
| 44486Q103 | HUMA | HUMACYTE INC | $142,368 | 0.91% | 83,500 | Common | SOLE |
| 85209E109 | — | SPRUCE BIOSCIENCES INC | $21,758 | 0.14% | 75,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.